Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer

Overview of attention for article published in Cochrane database of systematic reviews, March 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 12 tweeters

Citations

dimensions_citation: 28 Dimensions

Readers on

mendeley: 198 Mendeley

Summary Twitter Dimensions citations

So far, Altmetric has seen 14 tweets from 12 users, with an upper bound of 160,458 followers.

Ovarian function suppression for treating premenopausal women with hormone receptor‐positive early breast cancer https://t.co/91lUVskQpT New @CochraneBCancer systematic review included 15 studies involving 11,538 women; these studies were conducted from 19

18 Mar 2020

Reply Retweet Favourite

RT @WileyOnc_Hem: Ovarian function suppression for treating premenopausal women with hormone receptor‐positive early breast cancer. New @Co…

17 Mar 2020

Reply Retweet Favourite

Ovarian function suppression for treating premenopausal women with hormone receptor‐positive early breast cancer. New @CochraneBCancer systematic review included 15 studies involving 11,538 women #breastcancer @CochraneLibrary https://t.co/jTvxS2wMUU http

17 Mar 2020

Reply Retweet Favourite

RT @CochraneBCancer: New systematic review - ovarian function suppression for treating premenopausal women with hormone receptor‐positive e…

16 Mar 2020

Reply Retweet Favourite

This page shows the most recent tweets that mention this research output.

Click here to find out how to access more activity, including 10 additional tweets.